{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:17:56Z","timestamp":1782793076240,"version":"3.54.5"},"reference-count":32,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Non-functional well-differentiated pancreatic neuroendocrine tumors (WD-PanNETs) are complex, heterogeneous malignancies with variable prognosis. Despite guideline recommendations, disparities in access to specialized care may impact survival. This study examines whether treatment facility type, geographic travel distance, and treatment modalities are associated with survival outcomes in patients diagnosed with WD-PanNETs. Results: Among 20,174 patients with WD-PanNETs, the median age was 62 years (IQR: 52\u201370), and 54% were men. The majority were treated at non-academic hospitals (76%), with 2.9% traveling &gt;250 miles for care. Patients treated at non-academic hospitals (24%) had 50% lower 15-year survival rates compared to those treated at academic hospitals (58%) and integrated hospitals (56%) (p &lt; 0.001). Patients traveling &gt;250 miles had a 72% 15-year survival rate, compared to 43% for those traveling &lt;12.5 miles (p &lt; 0.001). In the context of facility-type and geographic distance, treatment at non-academic hospitals &lt;250 miles was associated with a 21% higher mortality risk (HR 1.21, 95% CI 1.12\u20131.31, p &lt; 0.001), and treatment at low-volume hospitals increased mortality risk by 25% (HR 1.25, 95% CI 1.14\u20131.37, p &lt; 0.001). In contrast, primary tumor resection was associated with a 64% reduction in mortality risk (HR 0.36, 95% CI 0.33\u20130.38, p &lt; 0.001), which remained significant at all disease stages. Conclusion: Treatment at academic or high-volume centers and longer travel distances were associated with improved OS in patients with WD-PanNETs. Primary tumor resection remains critical, while systemic therapies were primarily used in later-stage disease. These findings support policies that improve access to centralized, multidisciplinary care.<\/jats:p>","DOI":"10.3390\/cancers17183030","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:59:51Z","timestamp":1758088791000},"page":"3030","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Centralized Surgical Care Improves Survival in Non-Functional Well-Differentiated Pancreatic Neuroendocrine Tumors"],"prefix":"10.3390","volume":"17","author":[{"given":"Ahmed","family":"Alnajar","sequence":"first","affiliation":[{"name":"DeWitt Daughtry Department of Surgery, University of Miami Health System, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5238-227X","authenticated-orcid":false,"given":"Amber","family":"Collier","sequence":"additional","affiliation":[{"name":"DeWitt Daughtry Department of Surgery, University of Miami Health System, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Akcin","sequence":"additional","affiliation":[{"name":"DeWitt Daughtry Department of Surgery, University of Miami Health System, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I.","family":"Lew","sequence":"additional","affiliation":[{"name":"DeWitt Daughtry Department of Surgery, University of Miami Health System, Miami, FL 33136, USA"},{"name":"Division of Endocrine Surgery, DeWitt Daughtry Department of Surgery, University of Miami Health System, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-6733","authenticated-orcid":false,"given":"Tanaz M.","family":"Vaghaiwalla","sequence":"additional","affiliation":[{"name":"DeWitt Daughtry Department of Surgery, University of Miami Health System, Miami, FL 33136, USA"},{"name":"Division of Endocrine Surgery, DeWitt Daughtry Department of Surgery, University of Miami Health System, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1634\/theoncologist.2019-0466","article-title":"Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database","volume":"25","author":"Assi","year":"2020","journal-title":"Oncologist"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrgastro.2012.9","article-title":"Well-differentiated pancreatic neuroendocrine tumors: From genetics to therapy","volume":"9","author":"Edil","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e234096","DOI":"10.1001\/jamanetworkopen.2023.4096","article-title":"Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors","volume":"6","author":"Sugawara","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000457956","article-title":"ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification","volume":"105","author":"Perren","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00535-021-01827-7","article-title":"JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: Diagnosis, treatment, and follow-up: A synopsis","volume":"56","author":"Ito","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/MPA.0000000000001597","article-title":"The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors","volume":"49","author":"Halfdanarson","year":"2020","journal-title":"Pancreas"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jso.27225","article-title":"Care at high-volume centers is associated with improved outcomes for patients with pancreatic neuroendocrine tumors: A population-level analysis","volume":"127","author":"Patel","year":"2023","journal-title":"J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jso.26667","article-title":"It\u2019s more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors","volume":"124","author":"Underwood","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamasurg.2024.5009","article-title":"Travel to High-Volume Centers and Survival After Esophagectomy for Cancer","volume":"160","author":"Sakowitz","year":"2025","journal-title":"JAMA Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e234261","DOI":"10.1001\/jamanetworkopen.2023.4261","article-title":"Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients with Operable Malignant Pleural Mesothelioma","volume":"6","author":"Alnajar","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ijgc-2020-001807","article-title":"Impact of geography and travel distance on outcomes in epithelial ovarian cancer: A national cancer database analysis","volume":"31","author":"Daruvala","year":"2021","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/cncr.30744","article-title":"Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer","volume":"123","author":"Vetterlein","year":"2017","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/DCR.0000000000000924","article-title":"Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes","volume":"60","author":"Xu","year":"2017","journal-title":"Dis. Colon Rectum"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jss.2025.03.060","article-title":"Treatment at Academic Facilities Is Associated With Improved Survival in Late-Stage Colonic Neuroendocrine Tumors","volume":"310","author":"Suss","year":"2025","journal-title":"J. Surg. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/SLA.0000000000001924","article-title":"Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers","volume":"266","author":"Lidsky","year":"2017","journal-title":"Ann. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/cncr.23229","article-title":"Geographic access to cancer care in the US","volume":"112","author":"Onega","year":"2008","journal-title":"Cancer"},{"key":"ref_17","first-page":"908","article-title":"Management of Pancreatic Neuroendocrine Tumors: Surgical Strategies and Controversies","volume":"30","author":"Perry","year":"2024","journal-title":"Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/SLA.0000000000006331","article-title":"Charting the Course: Insights into Neuroendocrine Tumor Dynamics in the United States","volume":"281","author":"Wu","year":"2025","journal-title":"Ann. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.3399\/bjgp14X682837","article-title":"Referral interventions from primary to specialist care: A systematic review of international evidence","volume":"64","author":"Blank","year":"2014","journal-title":"Br. J. Gen. Pract. J. R. Coll. Gen. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2046-4053-3-30","article-title":"Socio-economic inequalities in patient, primary care, referral, diagnostic, and treatment intervals on the lung cancer care pathway: Protocol for a systematic review and meta-analysis","volume":"3","author":"Forrest","year":"2014","journal-title":"Syst. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1200\/JCO.2008.20.1715","article-title":"Centralization of cancer surgery: Implications for patient access to optimal care","volume":"27","author":"Stitzenberg","year":"2009","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/SLA.0b013e318211cc0f","article-title":"Wait times for cancer surgery in the United States: Trends and predictors of delays","volume":"253","author":"Bilimoria","year":"2011","journal-title":"Ann. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00535-019-01655-w","article-title":"Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis","volume":"55","author":"Kurita","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jso.26931","article-title":"Surgery or active surveillance for pNETs\u2009<\u20092\u2009cm: Preliminary results from a single center Brazilian cohort","volume":"126","author":"Arra","year":"2022","journal-title":"J. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s11605-019-04285-y","article-title":"Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors","volume":"24","author":"Barenboim","year":"2020","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-014-2615-0","article-title":"Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors","volume":"19","author":"Sharpe","year":"2015","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.surg.2019.04.061","article-title":"Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?","volume":"167","author":"Chivukula","year":"2020","journal-title":"Surgery"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/archsurg.2011.102","article-title":"Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: Short-term and long-term patient outcomes","volume":"146","author":"Haynes","year":"2011","journal-title":"Arch. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ben, Q., Zhong, J., Fei, J., Chen, H., Yv, L., Tan, J., and Yuan, Y. (2016). Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study. Sci. Rep., 6.","DOI":"10.1038\/srep36073"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Maharjan, C.K., Ear, P.H., Tran, C.G., Howe, J.R., Chandrasekharan, C., and Quelle, D.E. (2021). Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. Cancers, 13.","DOI":"10.3390\/cancers13205117"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.soc.2019.11.008","article-title":"Surgical Management of Pancreatic Neuroendocrine Tumors","volume":"29","author":"Vaghaiwalla","year":"2020","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-med-042320-011248","article-title":"Progress in the Management of Pancreatic Neuroendocrine Tumors","volume":"73","author":"Chang","year":"2022","journal-title":"Annu. Rev. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/18\/3030\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:45Z","timestamp":1760035605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/18\/3030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":32,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17183030"],"URL":"https:\/\/doi.org\/10.3390\/cancers17183030","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}